Anavex Life Sciences (AVXL) Short Interest Ratio & Short Volume → The “Next Bitcoin”? 10 CENT Crypto Set to Explode (From True Market Insiders) (Ad) Free AVXL Stock Alerts $3.44 +0.05 (+1.47%) (As of 04/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Anavex Life Sciences Short Interest DataCurrent Short Volume22,010,000 sharesPrevious Short Volume22,120,000 sharesChange Vs. Previous Month-0.50%Dollar Volume Sold Short$93.10 millionShort Interest Ratio / Days to Cover17.1Last Record DateApril 15, 2024Outstanding Shares82,110,000 sharesPercentage of Shares Shorted26.81%Today's Trading Volume949,972 sharesAverage Trading Volume1,228,255 sharesToday's Volume Vs. Average77% Short Selling Anavex Life Sciences ? Sign up to receive the latest short interest report for Anavex Life Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatAVXL Short Interest Over TimeAVXL Days to Cover Over TimeAVXL Percentage of Float Shorted Over Time Ad Banyan Hill PublishingForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)Watch my video for all of the details Anavex Life Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202422,010,000 shares $93.10 million -0.5%N/A17.1 $4.23 3/31/202422,120,000 shares $112.59 million +10.6%N/A17.3 $5.09 3/15/202420,000,000 shares $102.20 million -0.1%N/A13.4 $5.11 2/29/202420,020,000 shares $102.90 million +0.7%N/A13.9 $5.14 2/15/202419,890,000 shares $115.96 million -1.2%N/A13.7 $5.83 1/31/202420,130,000 shares $120.18 million -2.6%N/A13.9 $5.97 Get the Latest News and Ratings for AVXL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Anavex Life Sciences and its competitors with MarketBeat's FREE daily newsletter. 1/15/202420,660,000 shares $123.75 million +2.9%N/A14.4 $5.99 12/31/202320,070,000 shares $186.85 million +10.8%N/A14.8 $9.31 12/15/202318,120,000 shares $160.18 million +0.8%N/A16.6 $8.84 11/30/202317,970,000 shares $129.56 million -0.8%N/A17.6 $7.21 11/15/202318,120,000 shares $111.98 million -2.6%N/A18.8 $6.18 10/31/202318,610,000 shares $103.84 million +4.5%N/A20.3 $5.58 10/15/202317,810,000 shares $107.75 million -0.9%N/A20.5 $6.05 9/30/202317,970,000 shares $117.70 million +5.2%N/A21.8 $6.55 9/15/202317,090,000 shares $129.37 million +1.2%N/A20.4 $7.57 8/31/202316,880,000 shares $133.35 million +1.0%N/A19.3 $7.90 8/15/202316,720,000 shares $149.48 million +1.1%N/A18.5 $8.94 7/31/202316,540,000 shares $136.46 million -1.1%N/A18.1 $8.25 7/15/202316,730,000 shares $140.87 million -0.1%N/A18.8 $8.42 6/30/202316,740,000 shares $136.10 million -5.6%N/A17.8 $8.13 6/15/202317,740,000 shares $156.64 million +7.5%N/A17.9 $8.83 5/31/202316,510,000 shares $152.55 million +3.8%N/A15.9 $9.24 5/15/202315,900,000 shares $150.89 million +10.6%N/A15.9 $9.49 4/30/202314,380,000 shares $117.05 million -7.8%N/A13.7 $8.14 4/15/202315,590,000 shares $122.85 million -1.9%N/A14.4 $7.88 3/31/202315,890,000 shares $136.18 million +1.3%N/A13.8 $8.57 3/15/202315,680,000 shares $146.76 million -3.9%N/A13.2 $9.36 2/28/202316,320,000 shares $155.37 million -4.7%N/A7.5 $9.52 2/15/202317,130,000 shares $179.35 million +2.5%N/A7.4 $10.47 1/31/202316,720,000 shares $181.75 million -9.0%N/A7.1 $10.87 1/15/202318,370,000 shares $194.35 million +0.7%N/A8.1 $10.58 12/30/202218,250,000 shares $169.00 million +15.7%N/A8.2 $9.26 12/15/202215,780,000 shares $131.76 million +32.5%N/A7.3 $8.35 11/30/202211,910,000 shares $105.05 million +17.1%N/A6 $8.82 11/15/202210,170,000 shares $142.89 million +0.6%N/A11.6 $14.05 10/31/202210,110,000 shares $123.04 million +0.7%N/A12.7 $12.17 10/15/202210,040,000 shares $106.42 million -2.1%N/A12.5 $10.60 9/30/202210,260,000 shares $105.88 million +5.3%N/A13 $10.32 9/15/20229,740,000 shares $92.63 million +7.0%N/A12.1 $9.51 8/31/20229,100,000 shares $87.27 million +8.0%N/A10.6 $9.59These AI trades triggered this morning (545% return) (Ad)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy AVXL Short Interest - Frequently Asked Questions What is Anavex Life Sciences' current short interest? Short interest is the volume of Anavex Life Sciences shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 22,010,000 shares of AVXL short. Learn More on Anavex Life Sciences' current short interest. What is a good short interest ratio for Anavex Life Sciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AVXL shares currently have a short interest ratio of 17.0. Learn More on Anavex Life Sciences's short interest ratio. Which institutional investors are shorting Anavex Life Sciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Anavex Life Sciences: Simplex Trading LLC, DLD Asset Management LP, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Anavex Life Sciences' short interest increasing or decreasing? Anavex Life Sciences saw a drop in short interest in the month of April. As of April 15th, there was short interest totaling 22,010,000 shares, a drop of 0.5% from the previous total of 22,120,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Anavex Life Sciences' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Anavex Life Sciences: MeiraGTx Holdings plc (1.78%), Ocugen, Inc. (17.58%), Monte Rosa Therapeutics, Inc. (5.91%), SOPHiA GENETICS SA (0.10%), Jasper Therapeutics, Inc. (4.18%), Invivyd, Inc. (7.05%), Solid Biosciences Inc. (3.47%), Black Diamond Therapeutics, Inc. (3.35%), TScan Therapeutics, Inc. (1.09%), Tenaya Therapeutics, Inc. (5.41%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Anavex Life Sciences stock? Short selling AVXL is an investing strategy that aims to generate trading profit from Anavex Life Sciences as its price is falling. AVXL shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Anavex Life Sciences? A short squeeze for Anavex Life Sciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AVXL, which in turn drives the price of the stock up even further. How often is Anavex Life Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AVXL, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: MGTX Short Interest Data OCGN Short Interest Data GLUE Short Interest Data SOPH Short Interest Data JSPR Short Interest Data IVVD Short Interest Data SLDB Short Interest Data BDTX Short Interest Data TCRX Short Interest Data TNYA Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AVXL) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingUrgent Nvidia WarningAltimetryThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHis win rate puts Warren Buffett to shame… Investing DailyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press